You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Winners of this year's Breakthrough Prize in the life sciences include researchers who studied neurodegenerative disorders and protein folding.
Researchers uncovered a variant in the β1-adrenergic receptor gene that appears to influence how much sleep someone needs, the New York Times reports.
The $10 million initiative will include scientists from the University of California's campuses, as well as from governmental and nongovernmental organizations.
The researchers identified genes that specifically extend the lifespan of neurons and found genes that increase the number of neurites in the brain.
The New York Times writes that genes may influence when people prefer to sleep.
Researchers sequenced edits made at 1,656 on-target genomic sites in primary human T cells and used the data to train the model.
The UCSF spinout aims to develop noninvasive tests to detect kidney injury for the transplantation field and to diagnose and monitor chronic disease.
Using brain samples from individuals with or without multiple sclerosis, researchers detected declining projection neuron levels and related immune cell shifts.
With funding from the Bill and Melinda Gates Foundation, the Biohub will help implement metagenomic sequencing for infectious disease projects in 10 countries.
During the five-year collaboration, the partners will research disease-causing gene mutations and develop new CRISPR-based technologies for drug discovery.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.